{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:12:05Z","timestamp":1780917125353,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013873","name":"Government of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmcl.2025.130471","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:33:53Z","timestamp":1763346833000},"page":"130471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors"],"prefix":"10.1016","volume":"131","author":[{"given":"Ahmed","family":"Mamai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Morshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Prakesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Poda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandiaraju","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh M.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain D.G.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Marcellus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Theriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayome","family":"Abibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taira","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratheesh","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"O'Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil C.","family":"Pomroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Uehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Methvin","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert G.","family":"Priv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Al-awar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130471_bb0005","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bmcl.2025.130471_bb0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2025.130471_bb0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130471_bb0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccr.2005.03.037","article-title":"Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice","volume":"7","author":"Cattoretti","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmcl.2025.130471_bb0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of BCL6 in normal and transformed germinal center B cells","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bmcl.2025.130471_bb0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature09883","article-title":"BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition","volume":"473","author":"Duy","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130471_bb0035","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.celrep.2014.07.059","article-title":"The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130471_bb0040","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1158\/1078-0432.CCR-16-2071","article-title":"The expanding role of the BCL6 oncoprotein as a cancer therapeutic target","volume":"23","author":"Cardenas","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130471_bb0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big targets: drug discovery faces the protein-protein interaction challenge","volume":"15","author":"Scott","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130471_bb0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ccr.2009.12.050","article-title":"A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo","volume":"17","author":"Cerchietti","year":"2010","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130471_bb0055","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1172\/JCI85795","article-title":"Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma","volume":"126","author":"Cardenas","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2025.130471_bb0060","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1021\/acs.jmedchem.7b00313","article-title":"Discovery of a B-cell lymphoma 6 protein\u2013protein interaction inhibitor by a biophysics-driven fragment-based approach","volume":"60","author":"Kamada","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_bb0065","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1016\/j.bmc.2017.07.037","article-title":"Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design","volume":"25","author":"Yasui","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_bb0070","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1021\/acs.jmedchem.7b00359","article-title":"Discovery of pyrazolo[1,5-a] pyrimidine B-cell lymphoma 6 (BCL6) binders and optimization to high affinity macrocyclic inhibitors","volume":"60","author":"McCoull","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_bb0075","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1021\/acschembio.8b00698","article-title":"Development of a novel B-cell lymphoma 6 (BCL6) PROTAC to provide insight into small molecule targeting of BCL6","volume":"13","author":"McCoull","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130471_bb0080","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.celrep.2017.08.081","article-title":"Chemically induced degradation of the oncogenic transcription factor BCL6","volume":"20","author":"Kerres","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmcl.2025.130471_bb0085","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.bmc.2018.03.012","article-title":"A genetically selected cyclic peptide inhibitor of BCL6 homodimerization","volume":"26","author":"Osher","year":"2018","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130471_bb0090","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/acsmedchemlett.0c00111","article-title":"Rationally designed covalent BCL6 inhibitor that targets a tyrosine residue in the homodimer interface","volume":"11","author":"Teng","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130471_rf0095","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1021\/acs.jmedchem.9b02076","article-title":"Achieving in vivo target depletion through the discovery and optimization of benzimidazolone BCL6 degraders","volume":"63","author":"Bellenie","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_rf0100","doi-asserted-by":"crossref","first-page":"17079","DOI":"10.1021\/acs.jmedchem.1c00946","article-title":"Into deep water: optimizing BCL6 inhibitors by growing into a solvated pocket","volume":"64","author":"Lloyd","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_rf0105","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1021\/acs.jmedchem.1c02174","article-title":"Optimizing shape complementarity enables the discovery of potent tricyclic BCL6 inhibitors","volume":"65","author":"Davis","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_rf0110","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1021\/acs.jmedchem.3c00155","article-title":"Discovery of an in vivo chemical probe for BCL6 inhibition by optimization of tricyclic quinolinones","volume":"66","author":"Harnden","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_bb0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2021.12.035","article-title":"An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo","volume":"529","author":"Xing","year":"2022","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130471_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100928","article-title":"GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice","volume":"297","author":"Pearce","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130471_bb0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-023-06348-2","article-title":"Rewiring cancer drivers to activate apoptosis","volume":"620","author":"Gourisankar","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130471_rf0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116789","article-title":"Discovery of novel BCL6-targeting PROTACs with effective antitumoractivities against DLBCL in vitro and in vivo","volume":"277","author":"Mi","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_rf0135","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c01237","article-title":"Discovery of a selective and potent BCL6 PROTAC with efficacious antiproliferative activity for the areatment of diffuse large B-Cell Lymphoma","author":"Yu","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_or0005","unstructured":"www.ClinicalTrials.gov, ID NCT06090539. A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed\/Refractory Non-Hodgkin Lymphomas."},{"key":"10.1016\/j.bmcl.2025.130471_or0010","unstructured":"www.ClinicalTrials.gov, ID NCT06393738. A Study of ARV-393 in Relapsed\/Refractory Non-Hodgkin Lymphoma."},{"key":"10.1016\/j.bmcl.2025.130471_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/acsmedchemlett.2c00502","article-title":"Discovery of OICR12694: a novel, potent, selective, and orally bioavailable BCL6 BTB inhibitor","volume":"14","author":"Mamai","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130471_bb0130","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1021\/jm800382h","article-title":"Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design","volume":"51","author":"Wyatt","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130471_bb0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature03197","article-title":"Virtual screening of chemical libraries","volume":"432","author":"Shoichet","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130471_bb0140","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130471_bb0145","doi-asserted-by":"crossref","DOI":"10.1088\/2050-6120\/4\/2\/022001","article-title":"Fluorescence polarization assays in high-throughput screening and drug discovery: a review","volume":"4","author":"Hall","year":"2016","journal-title":"Methods Appl Fluoresc"},{"key":"10.1016\/j.bmcl.2025.130471_bb0150","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.2174\/138161206778743600","article-title":"Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology","volume":"12","author":"Huber","year":"2006","journal-title":"Curr Pharm Design"},{"key":"10.1016\/j.bmcl.2025.130471_bb0155","first-page":"3495","article-title":"Heck vinylations using vinyl sulfide, vinyl sulfoxide, vinyl sulfone, or vinyl sulfonate derivatives and aryl bromides catalyzed by a palladium complex derived from a tetraphosphine","author":"Battace","year":"2006","journal-title":"Synthesis"},{"key":"10.1016\/j.bmcl.2025.130471_bb0160","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1021\/ja111462h","article-title":"A domino approach (hydrolysis\/dehydrohalogenation\/Heck coupling) for the synthesis of styrene sulfonate salts","volume":"133","author":"Prakash","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130471_bb0165","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1021\/acsmedchemlett.0c00239","article-title":"Discovery of 3-quinazolin-4(3H)-on-3-yl-2,N-dimethylpropanamides as orally active and selective PI3K\u03b1 inhibitors","volume":"11","author":"Dong","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130471_bb0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/1521-3773(20020201)41:3<441::AID-ANIE441>3.0.CO;2-N","article-title":"The uronium\/guanidinium peptide coupling reagents: finally the true uronium salts","volume":"41","author":"Carpino","year":"2002","journal-title":"Angew Chem Int"},{"key":"10.1016\/j.bmcl.2025.130471_bb0175","first-page":"345","article-title":"Palladium-catalyzed vinylation of organic halides","volume":"27","author":"Heck","year":"1982","journal-title":"Org React"},{"key":"10.1016\/j.bmcl.2025.130471_bb0180","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/ejoc.201600469","article-title":"Styrylsulfonates and -sulfonamides through Pd-catalysed Matsuda\u2013Heck reactions of vinylsulfonic acid derivatives and arenediazonium salts","volume":"17","author":"Schmidt","year":"2016","journal-title":"Eur J Org Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:33:29Z","timestamp":1780914809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25003804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":41,"alternative-id":["S0960894X25003804"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130471","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130471"}}